ATE139343T1 - Kombinationen hepatitis-c-virus(hcv)-antigene zur anwendung in immunoassays für anti-hcv-antikörper - Google Patents
Kombinationen hepatitis-c-virus(hcv)-antigene zur anwendung in immunoassays für anti-hcv-antikörperInfo
- Publication number
- ATE139343T1 ATE139343T1 AT91302910T AT91302910T ATE139343T1 AT E139343 T1 ATE139343 T1 AT E139343T1 AT 91302910 T AT91302910 T AT 91302910T AT 91302910 T AT91302910 T AT 91302910T AT E139343 T1 ATE139343 T1 AT E139343T1
- Authority
- AT
- Austria
- Prior art keywords
- hcv
- domain
- combinations
- antigens
- antigen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
- G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Analytical Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Virology (AREA)
- Food Science & Technology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Communicable Diseases (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Thermistors And Varistors (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US50435290A | 1990-04-04 | 1990-04-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE139343T1 true ATE139343T1 (de) | 1996-06-15 |
Family
ID=24005897
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT95114016T ATE182684T1 (de) | 1990-04-04 | 1991-04-03 | Kombinationen der hepatitis-c-virus (hcv) antigene zur verwendung in immuntests für anti- hcv-antikörper |
AT91302910T ATE139343T1 (de) | 1990-04-04 | 1991-04-03 | Kombinationen hepatitis-c-virus(hcv)-antigene zur anwendung in immunoassays für anti-hcv-antikörper |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT95114016T ATE182684T1 (de) | 1990-04-04 | 1991-04-03 | Kombinationen der hepatitis-c-virus (hcv) antigene zur verwendung in immuntests für anti- hcv-antikörper |
Country Status (25)
Country | Link |
---|---|
EP (2) | EP0450931B1 (de) |
JP (1) | JP2733138B2 (de) |
KR (1) | KR100206150B1 (de) |
AT (2) | ATE182684T1 (de) |
BG (1) | BG61291B1 (de) |
BR (1) | BR9106309A (de) |
CY (1) | CY1881A (de) |
DE (2) | DE69131488T2 (de) |
DK (2) | DK0693687T4 (de) |
ES (2) | ES2134388T5 (de) |
FI (1) | FI106317B (de) |
GB (1) | GB2257784B (de) |
GR (2) | GR3020964T3 (de) |
HU (1) | HU217025B (de) |
IE (1) | IE911105A1 (de) |
IL (2) | IL97741A0 (de) |
LT (1) | LT3808B (de) |
LV (2) | LV10344A (de) |
MY (1) | MY107499A (de) |
NO (1) | NO310241B1 (de) |
PL (1) | PL172133B1 (de) |
RO (1) | RO109916B1 (de) |
RU (1) | RU2130969C1 (de) |
UA (1) | UA41266C2 (de) |
WO (1) | WO1991015771A1 (de) |
Families Citing this family (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
LU87861A1 (fr) | 1989-12-18 | 1991-10-08 | Wellcome Found | Agent viral |
US7166287B1 (en) | 1989-12-18 | 2007-01-23 | Glaxo Wellcome Inc. | Viral agent |
KR940000755B1 (ko) * | 1990-02-16 | 1994-01-29 | 유나이티드 바이오메디칼 인코오포레이티드 | Hcv에 대한 항체 검출, hcv 감염의 진단 및 백신으로서의 그 예방에 특히 적합한 합성 펩티드 |
US6194140B1 (en) | 1990-04-04 | 2001-02-27 | Chiron Corporation | HCV NS3 protein fragments having helicase activity and improved solubility |
ES2152922T3 (es) * | 1990-04-06 | 2001-02-16 | Genelabs Tech Inc | Epitopos del virus de la hepatitis c. |
CA2049679C (en) * | 1990-08-24 | 2005-06-21 | Sushil G. Devare | Hepatitis c assay utilizing recombinant antigens |
US6274148B1 (en) | 1990-11-08 | 2001-08-14 | Chiron Corporation | Hepatitis C virus asialoglycoproteins |
CZ289006B6 (cs) * | 1990-11-08 | 2001-10-17 | Chiron Corporation | Asialoglykoprotein hepatitis C viru, farmaceutická kompozice s jeho obsahem a jeho pouľití |
US5910404A (en) | 1990-12-14 | 1999-06-08 | Innogenetics N.V. | Synthetic antigens for the detection of antibodies to hepatitis C virus |
DE69029092T2 (de) * | 1990-12-14 | 1997-04-17 | Innogenetics N.V., Gent | Synthetische Antigene zum Nachweis von Antikörpern gegen Hepatitis C-Virus |
US6007982A (en) * | 1990-12-14 | 1999-12-28 | Innogenetics N.V. | Synthetic antigens for the detection of antibodies to hepatitis C virus |
DE4041304A1 (de) * | 1990-12-21 | 1992-06-25 | Mikrogen Molekularbiol Entw | Von strukturproteinen des hepatitis c-virus abgeleitete polypeptide, testkits, die diese polypeptide enthalten und impfstoffe gegen infektionen von hepatitis c-viren |
US5574132A (en) * | 1991-04-05 | 1996-11-12 | Biochem Immunosystems Inc. | Peptides and mixtures thereof for detecting antibodies to hepatitis C virus (HCV) |
AU3063992A (en) * | 1991-11-07 | 1993-06-07 | Dade International Inc. | Epitope mapping ot the c33c region of hcv |
EP0610436B9 (de) * | 1991-11-21 | 2003-03-26 | Common Services Agency | Detektion des Hepatis-C Virus. |
ATE219522T1 (de) * | 1992-02-04 | 2002-07-15 | Chiron Corp | Hepatistherapeutikum |
GB9203803D0 (en) * | 1992-02-21 | 1992-04-08 | Wellcome Found | A recombinant polypeptide |
UA39944C2 (uk) * | 1992-07-07 | 2001-07-16 | Чірон Корпорейшн | Спосіб визначення ранньої сероконверсії у ссавця-хазяїна до вірусу гепатиту с і набір для використання в способі |
EP0593291A3 (de) * | 1992-10-16 | 1995-03-15 | Evernew Biotech Inc | Nichtstrukturales Protein des Hepatitis C-Virus, sowie diagnostisches Verfahren und Testsatz. |
JP2778886B2 (ja) * | 1992-10-16 | 1998-07-23 | エバーニュー バイオテック インコーポレイティド | C型肝炎ウィルスのコア抗原タンパク質及びそれを用いての診断方法及びキット |
US6153378A (en) * | 1992-10-16 | 2000-11-28 | Bionova Corporation | Diagnosis of, and vaccination against, a positive stranded RNA virus using an isolated, unprocessed polypeptide encoded by a substantially complete genome of such virus |
WO1994013164A1 (en) | 1992-12-10 | 1994-06-23 | Nike International Ltd. | Bonding of rubber to plastic in footwear |
PL175360B1 (pl) * | 1993-05-10 | 1998-12-31 | Chiron Corp | Cząsteczka kwasu nukleinowego i kompozycja do wykrywania infekcji wirusa zapalenia wątroby typu C |
DE4428705A1 (de) * | 1994-08-12 | 1996-02-15 | Boehringer Mannheim Gmbh | Rekombinantes Antigen aus der NS3-Region des Hepatitis C Virus |
JPH0862219A (ja) * | 1994-08-19 | 1996-03-08 | Dainabotsuto Kk | 還元型抗原に対する抗体アッセイ試薬及びそれを使用した測定方法 |
JP3665371B2 (ja) * | 1994-08-31 | 2005-06-29 | 株式会社先端生命科学研究所 | C型肝炎ウイルス感染又はグループ判定のためのエピトープキメラ抗原ペプチド、その製法、及びそれを使用する感染又はグループ判定法 |
CA2172305A1 (en) * | 1995-03-30 | 1996-10-01 | Muneo Aoyama | Multiple antigenic peptide comprising at least two hepatitis c virus-associated peptides |
WO1996037606A1 (en) * | 1995-05-22 | 1996-11-28 | Bionova Corporation | Compositions and methods for the diagnosis of, and vaccination against, hepatitis c virus (hcv) |
FR2734639B1 (fr) * | 1995-05-26 | 1997-10-03 | Parteurop | Methode de pronostic de l'evolution d'une infection par le virus de l'hepatite c, et necessaire pour sa mise en oeuvre |
FR2737209B1 (fr) | 1995-07-25 | 1997-09-19 | Bio Merieux | Peptide capable d'etre reconnu par des anticorps reconnaissant l'antigene c33 du virus de l'hepatite c |
US6127116A (en) * | 1995-08-29 | 2000-10-03 | Washington University | Functional DNA clone for hepatitis C virus (HCV) and uses thereof |
JP3715027B2 (ja) | 1996-05-07 | 2005-11-09 | シスメックス株式会社 | C型肝炎ウイルス感染症診断薬 |
US7049428B1 (en) | 1998-03-04 | 2006-05-23 | Washington University | HCV variants |
US7338759B1 (en) | 1997-03-04 | 2008-03-04 | Washington University | HCV variants |
DK1021719T3 (da) * | 1997-09-22 | 2007-06-18 | Novartis Vaccines & Diagnostic | Fremgangsmåde til påvisning af antistoffer i en pröve |
AU6098900A (en) * | 1999-07-15 | 2001-02-05 | Bayer Corporation | The use of specific antibody titers to predict hepatic failure in people infected with hepatitis c virus |
JP2003512826A (ja) * | 1999-10-27 | 2003-04-08 | カイロン コーポレイション | Hcv特異的t細胞の活性化 |
US6986892B1 (en) * | 1999-11-24 | 2006-01-17 | Chiron Corporation | Immunogenic Hepatitis C virus non-structural polypeptides |
AU2574601A (en) * | 1999-11-24 | 2001-06-04 | Chiron Corporation | Novel hcv non-structural polypeptide |
US6630298B2 (en) | 2000-06-15 | 2003-10-07 | Chiron Corporation | HCV antigen/antibody combination assay |
US7491808B2 (en) | 2000-06-15 | 2009-02-17 | Novartis Vaccines And Diagnostics, Inc. | HCV non-structural protein mutants and uses thereof |
US7022830B2 (en) | 2000-08-17 | 2006-04-04 | Tripep Ab | Hepatitis C virus codon optimized non-structural NS3/4A fusion gene |
KR100801123B1 (ko) | 2000-08-17 | 2008-02-05 | 트리펩 아베 | 리바비린 함유 백신 및 이것의 사용 방법 |
US6858590B2 (en) | 2000-08-17 | 2005-02-22 | Tripep Ab | Vaccines containing ribavirin and methods of use thereof |
US6680059B2 (en) | 2000-08-29 | 2004-01-20 | Tripep Ab | Vaccines containing ribavirin and methods of use thereof |
FR2839722A1 (fr) | 2002-05-17 | 2003-11-21 | Bio Merieux | Nouvelles compositions peptidiques et leur utilisation notamment dans la preparation de compositions pharmaceutiques actives contre le virus de l'hepatite c |
ES2312806T3 (es) | 2002-09-09 | 2009-03-01 | Novartis Vaccines And Diagnostics, Inc. | Ensayo de vhc. |
AP2006003861A0 (en) | 2004-06-09 | 2006-12-31 | Pathogen Removal And Diagnosti | Particles embedded in a porous substrate for removing target analyte from a sample |
JP4005093B2 (ja) * | 2005-05-25 | 2007-11-07 | シスメックス株式会社 | C型肝炎ウイルス感染症診断薬および抗hcv抗体検出方法 |
JP2005274584A (ja) * | 2005-05-25 | 2005-10-06 | Sysmex Corp | C型肝炎ウイルス感染症診断薬の製造方法 |
US7968697B2 (en) | 2005-05-25 | 2011-06-28 | Chrontech Pharma Ab | Hepatitis C virus non-structural NS3/4A fusion gene |
ES2387321T3 (es) * | 2006-03-09 | 2012-09-20 | Transgene Sa | Proteína de fusión no estructural del virus de la hepatitis C |
US20080227111A1 (en) | 2007-03-16 | 2008-09-18 | Sysmex Corporation | Reagent kit and method for measuring hcv antibody |
US20090214593A1 (en) | 2007-08-16 | 2009-08-27 | Tripep Ab | Immunogen platform |
US8071561B2 (en) | 2007-08-16 | 2011-12-06 | Chrontech Pharma Ab | Immunogen platform |
FR2984328B1 (fr) | 2011-12-20 | 2016-12-30 | Bio-Rad Innovations | Procede de detection d'une infection par le virus de l'hepatite c |
WO2016069762A2 (en) * | 2014-10-29 | 2016-05-06 | Abbott Laboratories | Subject anti-hcv antibody detection assays employing ns3 capture peptides |
JP2018124277A (ja) * | 2017-02-02 | 2018-08-09 | 三洋化成工業株式会社 | 粒子含有組成物、免疫測定用試薬、免疫測定方法及び粒子の保存方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US390599A (en) | 1888-10-02 | Tool for weaver s use | ||
US456637A (en) | 1891-07-28 | Fence | ||
SE7804231L (sv) | 1978-04-14 | 1979-10-15 | Haessle Ab | Magsyrasekretionsmedel |
US4870008A (en) * | 1983-08-12 | 1989-09-26 | Chiron Corporation | Secretory expression in eukaryotes |
CA1341423C (en) † | 1984-10-31 | 2003-03-04 | Paul A. Luciw | Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome |
US4751180A (en) * | 1985-03-28 | 1988-06-14 | Chiron Corporation | Expression using fused genes providing for protein product |
DE3886363T3 (de) * | 1987-11-18 | 2004-09-09 | Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville | NANBV-Diagnostika |
WO1990011089A1 (en) † | 1989-03-17 | 1990-10-04 | Chiron Corporation | Nanbv diagnostics and vaccines |
LU87861A1 (fr) * | 1989-12-18 | 1991-10-08 | Wellcome Found | Agent viral |
CA2032907C (en) † | 1989-12-22 | 2002-05-14 | Richard R. Lesniewski | Hepatitis c assay |
-
1991
- 1991-03-29 KR KR1019920702437A patent/KR100206150B1/ko not_active IP Right Cessation
- 1991-03-29 HU HU9203146A patent/HU217025B/hu unknown
- 1991-03-29 BR BR919106309A patent/BR9106309A/pt not_active IP Right Cessation
- 1991-03-29 RU SU5053084A patent/RU2130969C1/ru active
- 1991-03-29 WO PCT/US1991/002225 patent/WO1991015771A1/en active IP Right Grant
- 1991-03-29 UA UA93004190A patent/UA41266C2/uk unknown
- 1991-03-29 PL PL91296329A patent/PL172133B1/pl unknown
- 1991-03-29 JP JP3507636A patent/JP2733138B2/ja not_active Expired - Lifetime
- 1991-03-29 RO RO92-01275A patent/RO109916B1/ro unknown
- 1991-04-01 IL IL97741A patent/IL97741A0/xx not_active IP Right Cessation
- 1991-04-01 IL IL170719A patent/IL170719A/en not_active IP Right Cessation
- 1991-04-02 MY MYPI91000551A patent/MY107499A/en unknown
- 1991-04-03 ES ES95114016T patent/ES2134388T5/es not_active Expired - Lifetime
- 1991-04-03 EP EP91302910A patent/EP0450931B1/de not_active Expired - Lifetime
- 1991-04-03 AT AT95114016T patent/ATE182684T1/de not_active IP Right Cessation
- 1991-04-03 IE IE110591A patent/IE911105A1/en unknown
- 1991-04-03 AT AT91302910T patent/ATE139343T1/de not_active IP Right Cessation
- 1991-04-03 DK DK95114016T patent/DK0693687T4/da active
- 1991-04-03 DE DE69131488T patent/DE69131488T2/de not_active Expired - Lifetime
- 1991-04-03 EP EP95114016A patent/EP0693687B2/de not_active Expired - Lifetime
- 1991-04-03 DK DK91302910.4T patent/DK0450931T3/da active
- 1991-04-03 ES ES91302910T patent/ES2088465T3/es not_active Expired - Lifetime
- 1991-04-03 DE DE69120138T patent/DE69120138T2/de not_active Expired - Lifetime
-
1992
- 1992-09-28 FI FI924349A patent/FI106317B/fi active
- 1992-09-28 GB GB9220480A patent/GB2257784B/en not_active Expired - Lifetime
- 1992-10-01 NO NO19923839A patent/NO310241B1/no not_active IP Right Cessation
- 1992-10-02 BG BG96943A patent/BG61291B1/bg unknown
-
1993
- 1993-05-31 LV LV930038D patent/LV10344A/en unknown
- 1993-05-31 LV LVP-93-438.1A patent/LV10344B/en unknown
- 1993-12-30 LT LTIP1747A patent/LT3808B/lt not_active IP Right Cessation
-
1996
- 1996-04-05 CY CY188196A patent/CY1881A/xx unknown
- 1996-09-05 GR GR960402319T patent/GR3020964T3/el unknown
-
1999
- 1999-09-29 GR GR990402455T patent/GR3031361T3/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE139343T1 (de) | Kombinationen hepatitis-c-virus(hcv)-antigene zur anwendung in immunoassays für anti-hcv-antikörper | |
NO934542D0 (no) | Hepatitt C virus (HCV) polypeptider | |
BRPI0111682B8 (pt) | suporte sólido de imunoensaio, kit de teste de imunodiagnóstico, métodos de produção de um suporte sólido de imunoensaio, e de detecção de infecção pelo vírus da hepatite c (hcv) em uma amostra biológica, e, uso de um suporte sólido de imunoensaio | |
DE3784484D1 (de) | Hepatitis nanb-viraler stoff, antigen und immunologisches reagenz. | |
UA39944C2 (uk) | Спосіб визначення ранньої сероконверсії у ссавця-хазяїна до вірусу гепатиту с і набір для використання в способі | |
KR890014729A (ko) | 비-a, 비-b형 간염 감염된 간에 대한 모노클로날 항체의 제조방법 | |
ATE410693T1 (de) | Hcv-test | |
PT97247A (pt) | Processo de preparacao de combinacoes de antigenios do virus da hepapite c (hcv) para uso em imunoensaios para anticorpos anti-hcv | |
TH11517EX (th) | การใช้แอนติเจนชนิดต่างๆของไวรัสตับอักเสบซี (hcv) ร่วมกัน เพื่อใช้ในการวิเคราะห์ทางอิมมูนสำหรับแอนติ - hcv แอนติบอดี | |
DK0599913T3 (da) | Monoklonale antistoffer mod formodet hepatitis C-virus NS5-proteiner og anvendelsesmetoder af samme | |
GEP19991558B (en) | Combination for Revealing Hepatitis C-Virus, Method for Revealing Antibodies and Set for Diagnosis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
EELA | Cancelled due to lapse of time |